This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- Pembro in Patients With HR+/HER2- mBC"

274 views
June 13, 2024

Chapters

SACI-IO HR+ Trial Overview

00:00

Clinical Trial Results & Patient Data

02:35

Safety Profile & Concluding Remarks

05:36

Comments 0
Login to view comments. Click here to Login